Patents for second medical indications and their potential impact on pharmacare in Canada.
نویسنده
چکیده
at Dalhousie University, Halifax, Nova Scotia. This article is based upon a report written by the author for Health Can ada. The au thor is gra teful for the assistance of Dr. Ingrid Sketris, Dr. Tim othy Pollak, Eleonar Hubbard, H olly R asky, and th e R esearch Group of the C ollege of Pharm acy at D alhousie Un ivers ity. The author w ould also like to thank Charles San ders, and research as sistant Josephine Asm ah. Any errors in the text of this document are the author’s. [2000] O.J. No. 4834. Patents for Second Medical Indications and Their Potential Impact on Pharmacare in Canada
منابع مشابه
National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability; Comment on “Universal Pharmacare in Canada: A Prescription for Equity in Healthcare”
Canada’s federal government intends to take steps to implement national pharmacare so that all Canadians have prescription drug coverage they need at an affordable price. Relatively limited funds have so far been pledged to support national pharmacare, which raises the question: what kind of program is envisioned? Since the government has already introduced regulations intended to reduce new dr...
متن کاملIt’s Time to Finally Kill the Zombies; Comment on “Universal Pharmacare in Canada”
The movement for a national pharmacare plan in Canada is growing, but at the same time the multinational pharmaceutical companies and their supporters are critical of such a move. The three major arguments that they make are that all that is needed is to “fill in the gaps,” ie, cover those who currently are uninsured or underinsured, that private drug plans are superior to public ones because t...
متن کاملUniversal Pharmacare in Canada: A Prescription for Equity in Healthcare
Despite progressive universal drug coverage and pharmaceutical policies found in other countries, Canada remains the only developed nation with a publicly funded healthcare system that does not include universal coverage for prescription drugs. In the absence of a national pharmacare plan, a province may choose to cover a specific sub-population for certain drugs. Altho...
متن کاملIt Won’t Be Easy: How to Make Universal Pharmacare Work in Canada
One of the glaring gaps in Canada’s universal healthcare system is the low level of public financing of prescription drugs - 42.7% of total spending in 2018. At the federal level there is renewed interest in moving towards universal coverage, supported by a recently commissioned report on how to achieve it. It will take superb political navigation to extract Canadian ph...
متن کاملThe Challenges of Projecting the Public Health Impacts of Marijuana Legalization in Canada; Comment on “Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts”
A recent editorial in this journal provides a summary of key economic, social, and public health considerations of the forthcoming legislation to legalize, regulate, and restrict access to marijuana in Canada. As our government plans to implement an evidence-based public health framework for marijuana legalization, we reflect and expand on recent discussions of the public health implications of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Health law journal
دوره 9 شماره
صفحات -
تاریخ انتشار 2001